 Latrepirdine attracted renewed interest in 2009 after being shown in small preclinical trials to have positive effects on persons suffering from Alzheimer's disease.Animal studies showing potential beneficial effects on Alzheimer's disease models were shown in Russian research in 2000.Preliminary results from human trials have also been promising.